Author Question: Nerve cells in the ________ control the pituitary gland by producing chemicals that either stimulate ... (Read 50 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
Nerve cells in the ________ control the pituitary gland by producing chemicals that either stimulate or suppress hormone secretions from the pituitary.
 
  Fill in the blank(s) with correct word

Question 2

The medical term anastomosis means:
 
  A) obstruction of a blood vessel by a foreign substance or blood clot.
  B) surgical connection between blood vessels.
  C) temporary opening into the abdomen.
  D) quivering or spontaneous contraction of individual muscle fibers.



jgranad15

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

hypothalamus

Answer to Question 2

B
Explanation: A) An embolism is the obstruction of a blood vessel by a foreign substance or blood clot.
B) Correct.
C) Laparotomy is an opening into the abdomen.
D) Fibrillation is the quivering or spontaneous contraction of individual muscle fibers.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library